+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82



Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in primary oral squamous cell carcinoma and corresponding metastases in cervical lymph nodes: association with the metastasis suppressor CD82



Anticancer Research 31(10): 3521-3526



Thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) are 5-fluorouracil (5-FU) metabolizing enzymes and are involved in the sensitivity of carcinoma patients to 5-FU. Although 5-FU is often used for the treatment of oral carcinoma, there has not been any investigation into the expression of these enzymes in metastatic lymph nodes or of their roles in the effectiveness of 5-FU in treating lymph node-metastatic cancer. Oral squamous cell carcinoma (OSCC) often metastasizes to the lymph nodes, and these enzymes may be significant in the survival of patients with this disease. This study investigated the expression of TS and DPD in cervical lymph node metastases and its relationship with primary OSCC, as well as the interaction between these enzymes and Kangai 1(KAI1/CD82) which is a metastasis suppressor protein. Surgical specimens from 20 cases of OSCC with lymph node metastasis, 20 cases of OSCC without lymph node metastasis, and 10 cases of normal mucosa were examined by immunohistochemistry. The relationship between TS and DPD expression and clinicopathological data was analyzed. TS and DPD proteins were overexpressed in primary OSCC compared to that in normal mucosa. TS expression of the primary oral cancer cells in the group with lymph node metastasis was higher than that of those without. DPD expression did not significantly correlate with the occurrence of lymph node metastasis, nor was it different between primary oral cancer cells and cervical metastases. CD82 expression was significantly reduced in lymph node metastases. These findings indicate that TS and CD82 may be of great value in assessing lymph node metastasis of OSCC, and could be taken as new targets for therapy of metastatic OSCC.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 053157865

Download citation: RISBibTeXText

PMID: 21965773


Related references

Evaluation of TS-1 based treatment and expression of thymidylate synthase and dihydropyrimidine dehydrogenase on oral squamous cell carcinoma. Oral Oncology 41(3): 276-282, 2005

Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 94(6): 717-723, 2002

Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in oral squamous cell carcinoma: possible markers as predictors of clinical outcome. Acta Oto-Laryngologica 126(12): 1295-1302, 2006

Expression levels of thymidylate synthase, thymidylate phosphorylase and dihydropyrimidine dehydrogenase in head and neck squamous cell carcinoma: preliminary study. Clinical Medicine. Oncology 2: 27-35, 2008

Study of Thymidylate Synthase (TS) and Dihydropyrimidine Dehydrogenase (DPD) Expressions on 5-Fluorouracil in Oral Squamous Cell Carcinoma. Asian Pacific Journal of Cancer Prevention 20(2): 503-508, 2019

An analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma. Relationship between grade of histopathological malignancy and lymph nodes metastasis. International Journal of Oral and Maxillofacial Surgery 32(3): 284-288, 2003

Expression of metastasis suppressor gene KAI1/CD82 in cervical squamous cell carcinoma and its clinical significance. Ai Zheng 24(1): 110-115, 2005

Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance. Oral Oncology 38(6): 557-561, 2002

Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. Archives of Oral Biology 52(8): 740-747, 2007

Clinical implications of thymidylate synthase and dihydropyrimidine dehydrogenase activities in head and neck squamous cell carcinoma. Journal of the Osaka City Medical Center 53(3-4): 133-142, 2004

Risk Factors Analysis of Pathologically Confirmed Cervical Lymph Nodes Metastasis in Oral Squamous Cell Carcinoma Patients with Clinically Negative Cervical Lymph Node: Results from a Cancer Center of Central China. Journal of Cancer 10(13): 3062-3069, 2019

Ultrasound diagnosis of cervical lymph node metastasis and histopathological characteristics of false negative lymph nodes in patients with oral squamous cell carcinoma. Sapporo Medical Journal 72(1-2): 15-21, 2003

Polymorphisms of thymidylate synthase gene and correlation of its protein expression to lymph node metastasis of esophageal squamous cell carcinoma. Ai Zheng 24(10): 1225-1229, 2005

Immunologic reaction of cervical lymph nodes in relation to metastasis and prognosis of oral squamous cell carcinoma. Zhonghua Kou Qiang Ke Za Zhi 15(1): 5-7, 1980

Expression of dihydropyrimidine dehydrogenase, orotate phosphoribosyl transferase and thymidylate synthase in patients with primary colorectal cancer, and associations with site of first metastasis. Anticancer Research 32(6): 2277-2282, 2012